Q32 Bio Inc. — Director's Dealing 2024

Mar 27, 2024

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Q32 Bio Inc. (QTTB)
CIK: 0001661998
Period of Report: 2024-03-25

Reporting Person: Iwicki Mark T (N/A)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$7.29	2031-01-21	Common Stock (37222)		Direct
Stock Option (Right to Buy)	$7.29	2031-12-16	Common Stock (7615)		Direct

Footnotes

F1: 25% of the shares underlying this option vested and became exercisable on January 4, 2022, with the remainder vesting in twelve (12) equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

F2: 25% of the shares underlying this option vested and became exercisable on December 17, 2022 with the remainder vesting in twelve (12) equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.